Publikationsliste der Klinik für Kardiologie und internistische Intensivmedizin

2021
  • Lawin D., Lawrenz T., Radke K., Stellbrink C. (2021). Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy. Clinical Research in Cardiology. doi: 10.1007/s00392-021-01960-6.
  • Lawrenz T., Lawin D., Radke K., Stellbrink C. (2021). Acute and Chronic Effects of Endocardial Radiofrequency Ablation of Septal Hypertrophy (ERASH) in HOCM. Journal of Cardiovascular Electrophysiology. doi: 10.1111/jce.15203.
  • Bode N., Hochadel M., Andresen D., Zahn R., Spitzer SG., Brachmann J., Stellbrink C., Jung W., Gonska BD., Reinke F., Senges J., Eckardt L. (2021). Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry. Int J Cardiol. doi: 10.1016/j.ijcard.2021.05.047
  • Costanzo MR., Javaheri S., Ponikowski P., Oldenburg O., Augostini R., Goldberg LR., Stellbrink C., Fox H., Schwartz AR., Gupta S., McKane S., Meyer TE., Abraham WT.; remedē®System Pivotal Trial Study Group. (2021). Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes. Nat Sci Sleep. doi: 10.2147/NSS.S300713
  • Delnoy PHM., Gutleben KJ., Bruun NE., Maier SKG., Oswald H., Stellbrink C., Johansen JB., Paule S., Søgaard P. (2021). Hemodynamic monitoring by intracardiac impedance measured by cardiac resynchronization defibrillators: Evaluation in a controlled clinical setting (BIO.Detect HF II study). Indian Pacing Electrophysiol J. doi: 10.1016/j.ipej.2021.04.003.
  • Lawin D., Lawrenz T., Radke K., Wolff A., Stellbrink C. (2021). Alcohol-induced Right Bundle Branch Block is associated with a benign Outcome in HOCM after Alcohol Septum Ablation. Clinical Research in Cardiology. doi: 10.1007/s00392-021-01847-6.
  • Pedretti RFE., Iliou MC., Israel CW., Abreu A., Miljoen H., Corrà U., Stellbrink C., Gevaert AB., Theuns DA., Piepoli MF., Reibis R., Schmid JP., Wilhelm M., Heidbuchel H., Völler H., Ambrosetti M., Deneke T., Cornelissen V., R Heinzel F., Davos CH., Kudaiberdieva G., Frederix I., Svendsen JH., Hansen D. (2021). Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA). Europace. doi: 10.1093/europace/euaa427.
  • Kaya E., Senges J., Hochadel M., Eckardt L., Andresen D., Ince H., Spitzer SG., Kleemann T., Maier SSK., Jung W., Stellbrink C., Rassaf T., Wakili R. (2021). Distribution and impact of age in patients with implantable cardioverter-defibrillators regarding early complications and 1-year clinical outcome: results from the German Device Registry. J Interv Card Electrophysiol. doi: 10.1007/s10840-020-00876-x.
  • Zuhorn F., Omaimen H., Ruprecht B., Stellbrink C., Rauch M., Rogalewski A., Klingebiel R., Schäbitz WR. (2021). Parainfectious encephalitis in COVID-19: "The Claustrum Sign". J Neurol. doi: 10.1007/s00415-020-10185-y.
2020
  • Nayak HM., Patel R., McKane S., James KJ., Meyer TE., Germany RE., Stellbrink C., Costanzo MR., Augostini R. (2020). Transvenous phrenic nerve stimulation for central sleep apnea is safe and effective in patients with concomitant cardiac devices. Heart Rhythm. doi: 10.1016/j.hrthm.2020.06.023.
  • Lawin D., Lawrenz T., Tego A., Stellbrink C. (2020). Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report. European Heart Journal - Case Reports. doi:10.1093/ehjcr/ytaa063.
  • Normand C., Linde C., Blomström-Lundqvist C., Stellbrink C., Gasparini M., Anker SD., Plummer C., Sarigul NU., Papiashvili G., Iovev S., Dickstein K. (2020). Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II. Europace. doi: 10.1093/europace/euaa067.
  • Lawin D., Stellbrink C. (2020). Implantierbarer Loop-Rekorder: Welche Indikationen sind vernünftig? Herzmedizin.
  • Kaya E, Senges J, Hochadel M, Eckardt L, Andresen D, Ince H, Spitzer SG, Kleemann T, Maier SSK, Jung W, Stellbrink C, Rassaf T, Wakili R. (2020). Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry. ESC Heart Fail. doi: 10.1002/ehf2.12613.
  • Bogossian H., Frommeyer G., Hochadel M., Ince H., Spitzer SG., Eckardt L., Maier SKG., Kleemann T., Brachmann J., Stellbrink C., Gonska BD., Kääb S., Senges J., Lemke B. (2020). Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry. Clin Res Cardiol. doi: 10.1007/s00392-019-01584-x.
2019
  • Lawin D., Israel CW., Linde C., Normand C., Dickstein K., Lober C., Gitt AK., Hindricks G., Stellbrink C.; members of the European CRT Survey II of the EHRA/HFA/ESC (2019). Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. Clinical Research in Cardiology. doi: 10.1007/s00392-019-01574-z.
  • Fox H., Oldenburg O., Javaheri S., Ponikowski P., Augostini R., Goldberg LR., Stellbrink C., Mckane S., Meyer TE., Abraham WT., Costanzo MR. (2019). Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep. doi: 10.1093/sleep/zsz158.
  • Frommeyer G., Reinke F., Andresen D., Kleemann T., Spitzer SG., Jehle J., Brachmann J., Stellbrink C., Hochadel M., Senges J., Eckardt L. (2020). Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry. Clin Res Cardiol. doi: 10.1007/s00392-019-01532-9.
  • Auricchio A., Gasparini M., Linde C., Dobreanu D., Cano Ó., Sterlinski M., Bogale N., Stellbrink C., Refaat MM., Blomström-Lundqvist C., Lober C., Dickstein K., Normand C. (2019). Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 Patients. JACC Clin Electrophysiol. doi: 10.1016/j.jacep.2019.06.003.
  • Hoffmann E., Straube F., Wegscheider K., Kuniss M., Andresen D., Wu LQ., Tebbenjohanns J., Noelker G., Tilz RR., Chun JKR., Franke A., Stellbrink C., Garcia-Alberola A., Dorwarth U., Metzner A., Ouarrak T., Brachmann J., Kuck KH., Senges J.; FREEZE Cohort Study Investigators. (2019). Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation. Europace. doi: 10.1093/europace/euz155.
  • Normand C., Linde C., Bogale N., Blomström-Lundqvist C., Auricchio A., Stellbrink C., Witte KK., Mullens W., Sticherling C., Marinskis G., Sciaraffia E., Papiashvili G., Iovev S., Dickstein K. (2019). Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II. Europace. doi: 10.1093/europace/euz002.
  • Lawin D., Stellbrink C. (2019). Change in indication for cardiac resynchronization therapy? European Journal of Cardio-Thoracic Surgery. doi: 10.1093/ejcts/ezy488.
  • Augostini RS., Afzal MR., Costanzo MR., Westlund R., Stellbrink C., Gutleben K., Gupta S., Saleem M., Smith TW., Peterson M., Drucker M., Merliss A., Hayes J., Butter C., Hutchinson M., Jagielski D. (2019). How to implant a phrenic nerve stimulator for treatment of central sleep apnea? J Cardiovasc Electrophysiol. doi: 10.1111/jce.13898.
  • Frommeyer G., Andresen D., Ince H., Maier S., Stellbrink C., Kleemann T., Seidl K., Hoffmann E., Zrenner B., Hochadel M., Senges J., Eckardt L. (2019). Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry. Heart Vessels. doi: 10.1007/s00380-018-01337-2.
  • Husser D., Christoph Geller J., Taborsky M., Schomburg R., Bode F., Nielsen JC., Stellbrink C., Meincke C., Hjortshøj SP., Schrader J., Lewalter T., Hindricks G. (2019). Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study. Eur Heart J Qual Care Clin Outcomes. doi: 10.1093/ehjqcco/qcy031.
2018
  • Stellbrink C., Sperzel J. (2018). New developments in cardiac implantable electronic devices. Herzschrittmacherther Elektrophysiol. doi: 10.1007/s00399-018-0596-5.
  • Meyer Zu Vilsendorf D., Hansky B., Baumann P., Stellbrink C. (2018). Troubleshooting in patients with implanted pacemaker and ICD. Dtsch Med Woschenschr. doi: 10.1055/a-0560-3180.
  • Stellbrink C., Hansky B., Baumann P., Lawin D. (2018). Transvenous neurostimulation in central sleep apnea associated with heart failure. Herzschrittmachertherapie und Elektrophysiologie. doi: 10.1007/s00399-018-0591-x.
  • Costanzo MR., Ponikowski P., Coats A., Javaheri S., Augostini R., Goldberg LR., Holcomb R., Kao A., Khayat RN., Oldenburg O., Stellbrink C., McKane S., Abraham WT.; remedē® System Pivotal Trial Study Group. (2018). Phrenic nerve stimulation to treat patients with central sleep apnoe and heart failure. Eur J Heart Fail. doi: 10.1002/ejhf.1312.
  • Lawin D., Hansky B., Baumann P., Stellbrink C. (2018). Heart on a string: a novel approach to managing difficult access to the left pericardiacophrenic vein for phrenic nerve stimulation. Herzschrittmachertherapie und Elektrophysiologie. doi: 10.1007/s00399-018-0587-6.
  • Stellbrink C., Hansky B., Meyer Zu Vilsendorf D. (2018). Leadless pacemakers and subcutaneously implantable cardioverter defibrillators. Internist (Berl). doi: 10.1007/s00108-018-0476-4.
  • Costanzo MR., Ponikowski P., Javaheri S., Augostini R., Goldberg LR., Holcomb R., Kao A., Khayat RN., Oldenburg O., Stellbrink C., Abraham WT.; remedē System Pivotal Trial Study Group. (2018). Sustained 12 Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea. Am J Cardiol. doi: 10.1016/j.amjcard.2018.02.022.
  • Dickstein K., Normand C., Auricchio A., Bogale N., Cleland JG., Gitt AK., Stellbrink C., Anker SD., Filippatos G., Gasparini M., Hindricks G., Blomström Lundqvist C., Ponikowski P., Ruschitzka F., Botto GL., Bulava A., Duray G., Israel C., Leclercq C., Margitfalvi P., Cano Ó., Plummer C., Sarigul NU., Sterlinski M., Linde C. (2018). CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. doi: 10.1002/ejhf.1142.
2017
  • Hansky B., Meyer Zu Vilsendorf D., Stellbrink C. (2017). Practical aspects of pacemaker indications. MMW Fortschr Med. doi: 10.1007/s15006-017-9043-5.
  • Köbe J., Andresen D., Maier S., Stellbrink C., Kleemann T., Gonska BD., Reif S., Hochadel M., Senges J., Eckardt L. (2017). Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry. Int J Cardiol. doi: 10.1016/j.ijcard.2016.11.212.
2016
  • Costanzo MR., Ponikowski P., Javaheri S., Augostini R., Goldberg L., Holcomb R., Kao A., Khayat RN., Oldenburg O., Stellbrink C., Abraham WT.; remedé System Pivotal Trial Study Group. (2016). Transvenous neurostimulation for central sleep apnoe: a randomized controlled trial. Lancet. doi: 10.1016/S0140-6736(16)30961-8.
2015
  • Costanzo MR., Augostini R., Goldberg LR., Ponikowski P., Stellbrink C., Javaheri S. (2015). Design of the remedē System Pivotal Trial: A Prospective, Randomized Study in the Use of Respiratory Rhythm Management to Treat Central Sleep Apnea. J Card Fail. doi: 10.1016/j.cardfail.2015.08.344.
  • Cohen A., Stellbrink C., Le Heuzey JY., Faber T., Aliot E., Banik N., Kropff S., Omran H.; SAFE-AF investigators. (2015). SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study. Arch Cardiovasc Dis. doi: 10.1016/j.acvd.2014.09.009.
  • Costanzo MR., Khayat R., Ponikowski P., Augostini R., Stellbrink C., Mianulli M., Abraham WT. (2015). Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol. doi: 10.1016/j.jacc.2014.10.025.
  • Dickstein K., Normand C., Anker SD., Auricchio A., Blomström-Lundqvisit C., Bogale N., Cleland J., Filippatos G., Gasparini M., Gitt A., Hindricks G., Kuck KH., Ponikowski P., Stellbrink C., Ruschitzka F., Linde C. (2015). European cardiac resynchronization therapy survey II: rationale and design. Europace. doi: 10.1093/europace/euu312.
2014
  • Schneider B., Athanasiadis A., Schwab J., Pistner W., Gottwald U., Schoeller R., Toepel W., Winter KD., Stellbrink C., Müller-Honold T., Wegner C., Sechtem U. (2014). Complications in the clinical course of tako-tsubo cardiomyopathy. Int J Cardiol. doi: 10.1016/j.ijcard.2014.07.002.
  • Veselka J., Lawrenz T., Stellbrink C., Zemanek D., Branny M., Januska J., Sitar J., Dimitrow P., Krejci J., Dabrowski M., Mizera S., Bartel T., Kuhn H. (2014). Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study. Catheter Cardiovasc Interv. doi: 10.1002/ccd.25236.
2013
  • International Working Group on Quantitative Optimization:, Sohaib SM., Whinnett ZI., Ellenbogen KA., Stellbrink C., Quinn TA., Bogaard MD., Bordachar P., van Gelder BM., van Geldorp IE., Linde C., Meine M., Prinzen FW., Turcott RG., Spotnitz HM., Wichterle D., Francis DP. (2013). Cardiac resynchronisation therapy optimisation strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing. Int J Cardiol. doi: 10.1016/j.ijcard.2013.10.069.
  • Stellbrink C., Hansky B. (2013). Device related infections. How to identify and how to treat. Herzschrittmacherther Elektrophyiol. doi: 10.1007/s00399-013-0286-2.
  • Hansky B., Kaymer W., zu Vilsendorf DM., Strunk-Müller C., Stellbrink C. (2013). Practical aspects of pacemaker and ICD-lead extractions. Herzschrittmacherther Elektrophysiol. doi: 10.1007/s00399-013-0282-6.
  • Köbe J., Wasmer K., Andresen D., Kleemann T., Spitzer SG., Jehle J., Brachmann J., Stellbrink C., Hochadel M., Senges J., Klein HU., Eckardt L. (2013). Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry. Int J Cardiol. doi: 10.1016/j.ijcard.2013.07.110.
  • Veselka J., Lawrenz T., Stellbrink C., Zemanek D., Branny M., Januska J., Groch L., Dimitrow P., Krejci J., Dabrowski M., Mizera S., Kuhn H. (2013). Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy. Can J Cardiol. doi: 10.1016/j.cjca.2013.04.027.
  • Butter C., Stellbrink C. (2013). Device associated complications. Herzschrittmacherther Elektrophysiol. d oi: 10.1007/s00399-013-0280-8.
  • Stellbrink C., Andresen D., Böcker D., Lewalter T. (2013). Implantable cardioverter defibrillator. Herzschrittmacherther Elektrophysiol. doi: 10.1007/s00399-013-0265-7.
  • Wasmer K., Köbe J., Andresen D., Zahn R., Spitzer SG., Jehle J., Brachmann J., Stellbrink C., Martens E., Hochadel M., Senges J., Klein H., Eckardt L. (2013). Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol. doi: 10.1007/s00392-013-0559-0.
2012
  • Bogale N., Priori S., Cleland JG., Brugada J., Linde C., Auricchio A., van Veldhuisen DJ., Limbourg T., Gitt A., Gras D., Stellbrink C., Gasparini M., Metra M., Derumeaux G., Gadler F., Buga L., Dickstein K.; Scientific Committee, National Coordinators, and Investigators. (2012). The European CRT Survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail. doi: 10.1093/eurjhf/hfr158.
2011
  • Stellbrink C. (2011). Cardiac resynchronisation therapy in asymptomatic patients with severely depressed left ventricular function. Dtsch Med Wochenschr. doi: 10.1055/s-0031-1272569.
  • Scheffold T., Kullmann S., Huge A., Binner P., Ochs HR., Schöls W., Thale J., Motz W., Hegge FJ., Stellbrink C., Dorsel T., Gülker H., Heuer H., Dinh W., Stoll M., Haltern G.; Forschungsverbund Herz-Kreislauf in NRW (Research Consortium Heart and Circulation in North Rhine-Westphalia). (2011). Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry. BMC Cardiovasc Disord. doi: 10.1186/1471-2261-11-9.
  • Lawrenz T., Borchert B., Leuner C., Bartelsmeier M., Reinhardt J., Strunk-Mueller C., Meyer Zu Vilsendorf D., Schloesser M., Beer G., Lieder F., Stellbrink C., Kuhn H. (2011). Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. J Am Coll Cardiol. doi: 10.1016/j.jacc.2010.07.055.
2010
  • Bocchiardo M., Meyer zu Vilsendorf D., Militello C., Lippert M., Czygan G., Schauerte P., Gaita F., Stellbrink C. (2010). Resynchronization therapy optimization by intracardiac impedance. Europace. doi: 10.1093/europace/euq273.
  • Stellbrink C. (2010). Arrhythmia recurrence after ablation of atrial fibrillation: should we be concerned about sleep apnoea? Europace. doi: 10.1093/europace/euq194.
  • Stellbrink C. (2010). What an emergency physician needs to know about acute care of cardiac arrhythmias. J Emerg Trauma Schock. doi: 10.4103/0974-2700.62109.
  • Bocchiardo M., Meyer zu Vilsendorf D., Militello C., Lippert M., Czygan G., Gaita F., Schauerte P., Stellbrink C. (2010). Intracardiac impedance monitors stroke volume in resynchronization therapy patients. Europace. doi: 10.1093/europace/euq045.
  • Leclercq C., Padeletti L., Cihák R., Ritter P., Milasinovic G., Gras D., Paul V., Van Gelder IC., Stellbrink C, Rieger G., Corbucci G., Albers B., Daubert JC.; CHAMP Study Investigators. (2010). Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace. doi: 10.1093/europace/eup318.
2009
  • Schlösser M., Stellbrink C. (2009). Indication for CRT. Herzschrittmacherther Elektrophysiol. doi: 10.1007/s00399-009-0050-9.